Trademark: 85474481
Word
CELL U RITE NATURALS
Status
Dead
Status Code
710
Status Date
Friday, August 14, 2020
Serial Number
85474481
Registration Number
4460807
Registration Date
Tuesday, January 7, 2014
Mark Type
3000
Filing Date
Wednesday, November 16, 2011
Published for Opposition
Tuesday, August 27, 2013
Cancellation Date
Friday, August 14, 2020

Trademark Owner History
Shirazi, Shawn - Original Registrant

Classifications
5 Goods containing or prepared from natural ingredients, namely, meal replacement powders, meal replacement bars, nutritional supplement energy bars, dietary fiber as a food additive, protein supplement shakes, meal replacement drinks, vitamin enhanced water, electrolyte drinks for medical purposes to treat dehydration, dietary supplements for promoting weight loss, herbal supplements for the promotion of healthy liver function, herbal supplements for the treatment of arthritis, herbal supplements for the treatment of cardiovascular disease, herbal supplements for the treatment of dental and oral diseases, herbal supplements for the treatment of headaches, herbal supplements for the treatment of cold and flu, herbal supplements for treating urinary tract infections, herbal supplements for the treatment of inflammatory diseases, namely, inflammatory bowel diseases and inflammatory connective tissue diseases, herbal supplements for the treatment of the musculoskeletal system, namely, connective tissue diseases, cartilage injuries, herbal supplements for the treatment of asthma, sinusitis, herbal supplements for use in dermatology, namely, acne, dermatitis, eczema, psoriasis, dietary supplement to treat digestive system discomforts, namely, blood sugar regulation, acid reflux, irritable bowel syndrome, herbal supplements to treat female hormonal imbalance, herbal supplements to treat mood disorders, edible fish oils for medical purposes, dietary and nutritional supplements containing omega fatty acids, mineral supplements, nutritional supplements for building body mass, dietary and food supplements containing whey, soy, rice, pea, and/or canola, vitamin supplements, dietary and herbal supplements to enhance energy and performance, medicated skin care preparations, pharmaceutical preparations for the relief of pain, pharmaceutical preparations for the treatment of acne, pharmaceutical preparations for the treatment of allergies, pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, pharmaceutical preparations for the treatment of cardiovascular diseases, pharmaceutical preparations for the treatment of carpal tunnel syndrome, pharmaceutical preparations for the treatment of chronic pain, pharmaceutical preparations for the treatment of dental and oral diseases, pharmaceutical preparations for the treatment of diabetes, pharmaceutical preparations for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, pharmaceutical preparations for the treatment of glaucoma, pharmaceutical preparations for the treatment of headaches, pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections, pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, pharmaceutical preparations for the treatment of migraine, pharmaceutical preparations for the treatment of motion sickness, pharmaceutical preparations for the treatment of myalgia and neuralgia, pharmaceutical preparations for the treatment of neurological diseases, namely, preparations for treatment of Alzheimer's disease, Huntington's disease and cerebral palsy, pharmaceutical preparations for the treatment of ophthalmological diseases and disorders, pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, internet addiction, drug addiction, pharmaceutical preparations for the treatment of psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, seizures, pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections, pharmaceutical preparations for the treatment of skin irritations, namely, bee stings, sunburn, rashes, sores, corns, calluses, and acne, pharmaceutical preparations for the treatment of smoking cessation, pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, pharmaceutical preparations for the treatment of the respiratory system, pharmaceutical preparations for the treatment of varicose veins, pharmaceutical preparations for the treatment of vascular diseases, pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, acquired immune deficiency syndrome (aids), pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, pharmaceutical preparations for use in gastroenterology, pharmaceutical preparations for use in ocular disorders, pharmaceutical preparations for use in oncology, pharmaceutical preparations for use in ophthalmology, radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use
Color is not claimed as a feature of the mark.
"NATURALS"
The mark consists of the stylized wording "CELL U RITE NATURALS" and a design comprised of a first leaf to the left of a second leaf, with the leaves situated above the center of an oblong that is divided in the middle by a curved separation, with the curved line formed by the separation of the sides of the oblong appearing to meet with the leaves in a manner suggesting that the leaves are on a stem, with the wording "CELL U RITE" appearing across the oblong design and the word "NATURALS" appearing beneath the oblong design.
CELL YOU RITE NATURALS

Trademark Events
Aug 14, 2020
Cancelled Sec. 8 (6-Yr)
Jan 7, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 8, 2016
Teas Change Of Correspondence Received
Jan 7, 2014
Registered-Principal Register
Nov 27, 2013
1(B) Basis Deleted; Proceed To Registration
Oct 22, 2013
Notice Of Allowance Cancelled
Nov 27, 2013
Case Assigned To Intent To Use Paralegal
Oct 22, 2013
Teas Delete 1(B) Basis Received
Oct 22, 2013
Noa E-Mailed - Sou Required From Applicant
Aug 27, 2013
Official Gazette Publication Confirmation E-Mailed
Aug 27, 2013
Published For Opposition
Aug 7, 2013
Notification Of Notice Of Publication E-Mailed
Jul 23, 2013
Law Office Publication Review Completed
Jul 22, 2013
Approved For Pub - Principal Register
Jul 19, 2013
Examiner's Amendment Entered
Jul 19, 2013
Notification Of Examiners Amendment E-Mailed
Jul 19, 2013
Examiners Amendment E-Mailed
Jul 19, 2013
Examiners Amendment -Written
Jul 18, 2013
Notification Of Non-Final Action E-Mailed
Jul 18, 2013
Non-Final Action E-Mailed
Jul 18, 2013
Non-Final Action Written
Jul 11, 2013
Previous Allowance Count Withdrawn
Jun 28, 2013
Withdrawn From Pub - Og Review Query
Jun 19, 2013
Law Office Publication Review Completed
Jun 17, 2013
Approved For Pub - Principal Register
May 30, 2013
Teas/Email Correspondence Entered
May 30, 2013
Correspondence Received In Law Office
May 24, 2013
Teas Response To Office Action Received
May 21, 2013
Notification Of Non-Final Action E-Mailed
May 21, 2013
Non-Final Action E-Mailed
May 21, 2013
Non-Final Action Written
Apr 30, 2013
Teas/Email Correspondence Entered
Apr 30, 2013
Correspondence Received In Law Office
Apr 23, 2013
Teas Response To Suspension Inquiry Received
Jan 29, 2013
Notification Of Letter Of Suspension E-Mailed
Jan 29, 2013
Letter Of Suspension E-Mailed
Jan 29, 2013
Suspension Letter Written
Jan 29, 2013
Assigned To Examiner
Jan 8, 2013
Teas/Email Correspondence Entered
Jan 8, 2013
Correspondence Received In Law Office
Jan 3, 2013
Teas Response To Suspension Inquiry Received
Jan 2, 2013
Notification Of Inquiry As To Suspension E-Mailed
Jan 2, 2013
Inquiry To Suspension E-Mailed
Jan 2, 2013
Suspension Inquiry Written
Dec 6, 2012
Lie Checked Susp - To Atty For Action
Jun 1, 2012
Notification Of Letter Of Suspension E-Mailed
Jun 1, 2012
Letter Of Suspension E-Mailed
Jun 1, 2012
Suspension Letter Written
May 10, 2012
Teas/Email Correspondence Entered
May 10, 2012
Correspondence Received In Law Office
May 3, 2012
Teas Response To Office Action Received
Mar 6, 2012
Notification Of Non-Final Action E-Mailed
Mar 6, 2012
Non-Final Action E-Mailed
Mar 6, 2012
Non-Final Action Written
Mar 2, 2012
Assigned To Examiner
Feb 27, 2012
Teas/Email Correspondence Entered
Feb 27, 2012
Correspondence Received In Law Office
Feb 15, 2012
Assigned To Lie
Feb 7, 2012
Teas Voluntary Amendment Received
Nov 23, 2011
Notice Of Design Search Code Mailed
Nov 22, 2011
New Application Office Supplied Data Entered In Tram
Nov 19, 2011
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24